Long Term Outcomes of Biliary Hyperkinesia

Overview

About this study

The purpose of this study’s aim is to determine the long term outcomes ascertain positive role of laparoscopic cholecystectomy for the treatment of Biliary Hyperkinesia.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Patients who underwent laparoscopic cholecystectomy for Biliary Hyperkinesia, from 2013-2023.

Exclusion Criteria:

Patients who are deceased or have no contact information.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 5/01/2024. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Scottsdale/Phoenix, Ariz. Mayo Clinic principal investigator Irving Jorge, M.D.	Open for enrollment	Contact information: Andrew Saleeb (480) 574-2189 Saleeb.Andrew@mayo.edu

Mayo Clinic Location

Status

Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Irving Jorge, M.D.

Open for enrollment

Contact information:

Andrew Saleeb

(480) 574-2189

Saleeb.Andrew@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials